Cargando…
Impact of Education on Fluoroquinolone Use in Uncomplicated Cystitis
BACKGROUND: The Food and Drug Administration released a safety alert in May 2016 against the use of fluoroquinolones (FQ) in uncomplicated infections including uncomplicated cystitis due to concern for increased risk of disabling and potentially permanent adverse drug effects (ADEs). The aim of the...
Autores principales: | Ferren, Ryan, Lee, Helen, Park, Steven, Thrupp, Lauri, Hsieh, Lanny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631353/ http://dx.doi.org/10.1093/ofid/ofx163.1258 |
Ejemplares similares
-
70. Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
por: Hayden, Dillon, et al.
Publicado: (2020) -
Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
por: Hayden, Dillon A, et al.
Publicado: (2023) -
2840. Prevalence of Acute Uncomplicated Cystitis in Japan
por: Franklin, Meg, et al.
Publicado: (2023) -
Long-term impact of fluoroquinolone-sparing strategies for empirical
treatment of acute uncomplicated cystitis among ambulatory
patients
por: Kon, Shelley, et al.
Publicado: (2022) -
1115. Use of a Fluoroquinolone (FQ) vs. a Non-Fluoroquinolone (Non-FQ)-Based Antibiotic Regimen in the Treatment of Acute, Uncomplicated Diverticulitis
por: Mourani, Jessyca, et al.
Publicado: (2018)